Showing 35,310 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined aidsmap in 2008 and was Managing Editor from 2018 to 2024. As a freelancer, he now edits aidsmap’s news and conference coverage, as well as working on updates to About HIV pages. He is also a contributing science editor for TheBodyPro, a freelance journalist for The Lancet HIV, and a medical writer helping researchers prepare articles for peer-reviewed journals. He began working on HIV at Gay Men Fighting AIDS in the mid-1990s.

How HIV works

Virus detectives test whole-body scans in search of HIV’s hiding places

Editor's pick
Nature
23 October 2018
Drug-resistant TB

Johnson & Johnson prices keep key TB medicines out of reach

Editor's pick
MSF
23 October 2018
Drug-resistant TB

DR-TB Drugs Under the Microscope, 5th Edition

Editor's pick
MSF
23 October 2018
PrEP programmes & uptake

380,000 people on PrEP globally, mostly in the USA and Africa [updated]

News
23 October 2018
The search for an HIV prevention vaccine

New Global HIV Vaccine Enterprise Strategic Plan lays out a roadmap to speed the development of a safe and effective vaccine against HIV

Editor's pick
International AIDS Society
23 October 2018
People & personal stories

SA scientist honoured by HIV community

Editor's pick
Health-e News
23 October 2018
Women

Young women, their male partners and HIV – how relationships vary across settings

Editor's pick
AVERT
23 October 2018
Harm reduction

US: The Harm Reduction Movement: Bigger Than Ever, But Facing Threats

Editor's pick
Filter
23 October 2018
PEP

New York City's Hotline for HIV Exposure a Success, Study Finds

Editor's pick
The Body Pro
23 October 2018
Chemsex & recreational drug use

Club drug GHB associated with brain and cognitive changes

Editor's pick
Science Daily
23 October 2018
Retention & linkage to care

Viral suppression within three months of HIV diagnosis should be a policy target, NYC officials say

News
23 October 2018
Exposure to HIV through medical procedures

New tainted blood scandal: Patients infected with HIV were each paid around £24,000 to sign away their rights to sue – before being told they’d also contracted hepatitis C

Editor's pick
Daily Mail
22 October 2018
Child developmental issues

Dolutegravir Use During Pregnancy: What Are the Risks?

Editor's pick
Infectious Disease Advisor
22 October 2018
Transgender people

‘Transgender’ Could Be Defined Out of Existence Under Trump Administration

Editor's pick
New York Times
22 October 2018
People & personal stories

‘Fear overcome by love’: why I participated in HIV cure research

Editor's pick
Journal of Virus Eradication
22 October 2018
Health monitoring in resource-limited settings

Drug resistance accumulates fast in people with low but detectable viral loads, Kenyan study finds

News
22 October 2018
PrEP policies & guidelines

PrEP: NHS 'must urgently offer' HIV breakthrough nationwide as study shows infections cut 25% in a year

Editor's pick
The Independent
22 October 2018
People & personal stories

Do some people really want to get HIV? I spoke to ‘bug chasers’ around the world to find out

Editor's pick
The Conversation
22 October 2018
Improving HIV care

Why integrating HIV with non-HIV services in Uganda won’t work

Editor's pick
The Conversation
22 October 2018
History of HIV & AIDS

Thirty Years Later, AIDS Activists Who ‘Seized Control’ Discuss Their Legacy

Editor's pick
My Fabulous Disease
22 October 2018
PrEP policies & guidelines

Malawi: Sex workers demand access to PrEP

Editor's pick
Key Correspondents
22 October 2018
New & experimental HIV treatments

ViiV Seeks FDA Approval for Two-Drug HIV Treatment

Editor's pick
Poz
22 October 2018
PrEP policies & guidelines

CDC Encourages Health Care Providers to “Prescribe HIV Prevention”

Editor's pick
Poz
22 October 2018
The search for a cure

Second case of potential HIV eradication

Editor's pick
HIV i-Base
22 October 2018